Coronavirus Update: Regeneron's REGEN-COV Authorized For Prevention

Regeneron's antibody cocktail gets emergency authorization for post-exposure prophylaxis from the US FDA. Daewoong's camostat shows efficacy in older patients in South Korean trial. 

3D_Coronavirus

Regeneron Pharmaceuticals, Inc.can tap into a broader market opportunity in the COVID-19 pandemic with an expansion to the authorization of its two-antibody drug cocktail to include post-exposure prophylaxis against SARS-CoV-2 infection.

The US Food and Drug Administration said 30 July that it had revised the emergency use authorization (EUA) of REGEN-COV...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip